Prof. Dr. Mutlu DOĞAN | AVESİS

Akademik Veri Yönetim Sistemi

Desteklenen Projeler

Desteklenen Projeler 1

2025 - Devam Ediyor TITLE PAGE A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Diğer Uluslararası Fon Programları

DOĞAN M.